Candel Therapeutics, Inc. Rings the Closing Bell in Celebration of its IPO
ABOUT THIS EVENT
Candel Therapeutics, Inc. (Nasdaq: CADL) visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Paul Peter Tak, M.D., Ph.D., FMedSci, President & CEO, rings the Closing Bell.